A Review of Recent Patents Concerning Therapy of Respiratory Diseases Using Gene Silencing by RNAi (RISC) and EGS (RNAse P)
Recent Patents on Inflammation & Allergy Drug Discovery · 2007
DOI: 10.2174/187221307779815147 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Recent Patents on Inflammation & Allergy Drug Discovery, 2007. Verfasst von David H Dreyfus und 1 weiteren Autor:innen. Beteiligte Einrichtung: Pediatrics, Yale School of Medicine and Medical Director, Founder Keren Pharmaceutical Inc., 488 Norton Parkway, New Haven CT 06511, USA. dhdreyfus@p…. Hauptthemen laut MEDLINE: RNA Interference. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Pediatrics, Yale School of Medicine and Medical Director, Founder Keren Pharmaceutical Inc., 488 Norton Parkway, New Haven CT 06511, USA. dhdreyfus@pol.net
Zitieren
APA
Dreyfus, D. H., & Ghoda, L. (2007). A Review of Recent Patents Concerning Therapy of Respiratory Diseases Using Gene Silencing by RNAi (RISC) and EGS (RNAse P). Recent Patents on Inflammation & Allergy Drug Discovery. https://doi.org/10.2174/187221307779815147
Vancouver
Dreyfus DH, Ghoda L. A Review of Recent Patents Concerning Therapy of Respiratory Diseases Using Gene Silencing by RNAi (RISC) and EGS (RNAse P). Recent Patents on Inflammation & Allergy Drug Discovery. 2007. doi:10.2174/187221307779815147
BibTeX
@article{Dreyfus2007,
author = {Dreyfus, David H and Ghoda, Lucy},
title = {A Review of Recent Patents Concerning Therapy of Respiratory Diseases Using Gene Silencing by RNAi (RISC) and EGS (RNAse P)},
journal = {Recent Patents on Inflammation & Allergy Drug Discovery},
year = {2007},
doi = {10.2174/187221307779815147}
}
EUVIMED